Ascendis Pharma A/S Profit Margin

The latest profit margin for ASND is 71.69% as of June 2026. That compares with -55.25% in the prior-year period — up 229.7% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Ascendis Pharma A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, ASND's profit margin moved from -55.25% to 71.69% — a 229.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ascendis Pharma A/S's valuation or profitability profile.

Against Healthcare companies, ASND currently prints 71.69% for profit margin, while the sector average sits near 13.89%. That is roughly 416.0% above the sector mean. Large gaps often invite a closer look at Ascendis Pharma A/S's growth, margins, and balance sheet.

Profit Margin shows how effectively Ascendis Pharma A/S converts resources into returns. At 71.69%, ASND may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -55.25% in the prior-year period — up 229.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ASND's profit margin (71.69%), review year-over-year change from -55.25%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.